FDA Drug recall D-0602-2018
Valacyclovir Tablets USP 1 gram, 30-count bottle, Rx Only, Manufactured for Camber Pharmaceuticals, Inc
- FDA Drug
- Class II
- terminated
- Published 2018-03-21
On 2018-03-21 the FDA classified a Class II recall of Valacyclovir Tablets USP 1 gram, 30-count bottle, Rx Only, Manufactured for Camber Pharmaceuticals, Inc by Hetero Labs Unit V, citing temperature Abuse: Valganciclovir Tablets USP 450 mg and Valacyclovir Tablets USP 1 gram were exposed to higher temperature at airport or cargo and in the same consignment of Famc….
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0602-2018 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2018-02-13 |
| Published | 2018-03-21 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Hetero Labs Unit V |
| Distribution | US |
Product
Valacyclovir Tablets USP 1 gram, 30-count bottle, Rx Only, Manufactured for Camber Pharmaceuticals, Inc. Piscataway, NJ 08854 By: Hetero Hetero Labs Limit Unit V Pollypally Jadcherla Mahaboob Nagar - 509 301 India NDC # 31722-705-30
Reason
Temperature Abuse: Valganciclovir Tablets USP 450 mg and Valacyclovir Tablets USP 1 gram were exposed to higher temperature at airport or cargo and in the same consignment of Famciclovir complaint batch (D-0415-2018).
Identifiers
| ndc | 31722-704-30 |
|---|---|
| ndc | 31722-704-60 |
| ndc | 31722-704-90 |
| ndc | 31722-704-01 |
| ndc | 31722-704-05 |
| ndc | 31722-704-31 |
| ndc | 31722-704-32 |
| ndc | 31722-705-30 |
| ndc | 31722-705-60 |
| ndc | 31722-705-90 |
| ndc | 31722-705-01 |
| ndc | 31722-705-05 |
| code_info | Lot # VLC17027 Exp 07-2019 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0602-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.